3689 Stock Overview
An investment holding company, primarily operates private hospitals in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 3689 from our risk checks.
Guangdong Kanghua Healthcare Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$2.56 |
| 52 Week High | HK$2.85 |
| 52 Week Low | HK$1.38 |
| Beta | 0.60 |
| 11 Month Change | -1.54% |
| 3 Month Change | 8.94% |
| 1 Year Change | 75.34% |
| 33 Year Change | -37.41% |
| 5 Year Change | -44.95% |
| Change since IPO | -75.85% |
Recent News & Updates
Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now
Jun 19
Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?
Jun 10Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too
May 22Recent updates
Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now
Jun 19Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?
Jun 10Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too
May 22Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal
Nov 28Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)
May 09Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal
Feb 02Here's Why Guangdong Kanghua Healthcare (HKG:3689) Can Manage Its Debt Responsibly
Nov 08Some Investors May Be Worried About Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital
Sep 06Investors Could Be Concerned With Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital
May 31Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)
Jan 25Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal
Sep 21Is Guangdong Kanghua Healthcare (HKG:3689) Using Too Much Debt?
May 03Do Insiders Own Lots Of Shares In Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689)?
Feb 04
Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque
Dec 14Shareholder Returns
| 3689 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | -7.6% | 0.008% | -2.0% |
| 1Y | 75.3% | -30.7% | -4.9% |
Return vs Industry: 3689 exceeded the Hong Kong Healthcare industry which returned -30.7% over the past year.
Return vs Market: 3689 exceeded the Hong Kong Market which returned -4.9% over the past year.
Price Volatility
| 3689 volatility | |
|---|---|
| 3689 Average Weekly Movement | 8.6% |
| Healthcare Industry Average Movement | 5.7% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in HK Market | 13.7% |
| 10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 3689 has not had significant price volatility in the past 3 months.
Volatility Over Time: 3689's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 3,946 | Wangzhi Chen | www.kanghuagp.com |
Guangdong Kanghua Healthcare Co., Ltd., an investment holding company, primarily operates private hospitals in the People’s Republic of China. The company operates through four segments: Hospital Services, Rehabilitation and Other Healthcare Services, and Elderly Healthcare Services. It provides inpatient and outpatient healthcare, and physical examination services.
Guangdong Kanghua Healthcare Co., Ltd. Fundamentals Summary
| 3689 fundamental statistics | |
|---|---|
| Market cap | HK$912.90m |
| Earnings (TTM) | HK$131.60m |
| Revenue (TTM) | HK$2.22b |
6.5x
P/E Ratio0.4x
P/S RatioIs 3689 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3689 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.04b |
| Cost of Revenue | CN¥1.70b |
| Gross Profit | CN¥344.37m |
| Other Expenses | CN¥223.31m |
| Earnings | CN¥121.06m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.36 |
| Gross Margin | 16.87% |
| Net Profit Margin | 5.93% |
| Debt/Equity Ratio | 21.3% |
How did 3689 perform over the long term?
See historical performance and comparison